Press Releases

Association for Molecular Pathology Develops Standardized Biomarker Report Template for Providers

AMP announced the publication of a new simplified, consensus-driven NGS molecular biomarker report designed to support oncologists and other healthcare providers. This report provides clear, practical recommendations to help laboratories present complex molecular profiling data in a format that is both clinically useful and consistent with current guidelines.

Phastar Scoops Multiple Finalist Positions in 2025 SCRIP Awards

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as finalists in two categories at the prestigious 2025 SCRIP Awards.

Baylor Genetics Earns 2025 Great Place To Work Certification™

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, is proud to be Certified™ by Great Place To Work®! The prestigious award is based entirely on what current employees say about their experience working at Baylor Genetics. This recognition is based entirely on feedback from current employees about their workplace experience. In 2025, Baylor Genetics employees rated the company 17 points higher than the average U.S. workplace.

Clearwater Receives Strategic Growth Investment from Sunstone Partners

Ambience Healthcare Becomes First Ambient AI Platform to Launch Inpatient CDI at the Point of Care, Built on OpenAI

P&C Labs Achieves Immediate Efficiency Gains with Proscia’s Software

Pathologists readily embrace the shift to digital workflows.

Scanogen Awarded NIH 2.9M Grant to Advance Rapid Test for Life-Threatening Bloodstream Infections

Baltimore, MD – Sept 22, 2025 – Scanogen Inc. has received a $2.9 million grant from the NIH/NIAID to scale its rapid diagnostic platform for life-threatening yeast bloodstream infections. Powered by proprietary SMART technology, the system delivers results directly from blood samples in hours—far faster than traditional blood cultures. The funding will support FDA-compliant production, software upgrades, and preparation for clinical trials. CEO Dr. Al Celedon stated the grant is a major step toward faster diagnosis and improved patient survival.

ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test

ClearNote Health receives UKCA markings for both the Avantect Ovarian Test and the Avantect Multi-Cancer Detection Test.

Takara Bio Europe Launches Cellartis® MSC EV Wonder™, a Defined, Xeno-Free Medium for High-Yield EV Production

Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder

Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity

Proscia to Expand Pathology AI Capabilities with Virtual Staining

Delivering a menu of H&E, IHC, and special stains on the Concentriq platform

Carolina Molecular Inc. and Astoriom to Collaborate on Integrated Molecular Testing and Biospecimen Storage Services

Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech Partners

Arkivum announces new partnership with unified trial management platform provider PHARMASEAL

Arkivum is delighted to announce a new partnership with PHARMASEAL, the provider of the Engility® Trial Management Platform, consisting of a Clinical Trial Management System (CTMS) and Electronic Trial Master File (eTMF).

electronRx to Launch pDx App for Remote Chronic Respiratory Disease Management

● Technology detects digital biomarkers to help monitor lung function and optimise therapeutic outcomes for patients ● electronRx to showcase pDx at HLTH 2025 (19–22 Oct, Las Vegas)

Baylor Genetics’ Chief Medical Officer Dr. Christine Eng Named Woman Scientist of the Year in 2025 Stevie® Awards for Women in Business

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced that Chief Medical Officer and Chief Quality Officer Dr. Christine Eng has been named Woman Scientist of the Year in the 22nd annual Stevie Awards for Women in Business.

Proscia Expands AWS Collaboration to Advance Precision Medicine with AWS HealthImaging Integration

AWS HealthImaging integration delivers standards-based digital pathology at enterprise scale with DICOM and Proscia’s cloud-native platform

DNAnexus and Oracle Join Forces to Deliver Genomic Insights at the Point of Care

Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history.

Logical Biological and Bcell Design Announce Strategic Partnership for Engineered Disease State Materials

Logical Biological, biospecimen and critical raw material leader, and Bcell Design, pioneers in transgenic monoclonal antibody technology, today announced a long term strategic partnership to deliver engineered disease state materials for diagnostic and research markets.

Precision BioLogic Leads the Way in Hemophilia Testing: Proven CRYOcheck™ Chromogenic Factor VIII assay now offers expanded utility in anticipation of emerging treatments

Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the expanded utility of its CRYOcheck Chromogenic Factor VIII assay in anticipation of emerging hemophilia treatments such as Mim8, a next generation bispecific antibody for the treatment of hemophilia A. The updated assay will ensure labs are ready and able to deliver accurate results when new treatments become available.

Proscia Unveils Aperture, Making the Moment of Diagnosis the Gateway to Life-Saving Treatments for More Patients

For participating academic medical centers, healthcare systems, and reference laboratories, Proscia Aperture elevates pathology from a diagnostic function to a strategic revenue driver.